Skip to main content
Veterinary Medicines

Vitol-140, süstelahus veistele, hobustele, sigadele ja lammastele

Authorised
  • ALPHATOCOPHEROL ACETATE
  • Colecalciferol
  • Retinol palmitate

Product identification

Medicine name:
Vitol-140, süstelahus veistele, hobustele, sigadele ja lammastele
Active substance:
  • ALPHATOCOPHEROL ACETATE
  • Colecalciferol
  • Retinol palmitate
Target species:
  • Cattle
  • Horse
  • Pig
  • Sheep
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • ALPHATOCOPHEROL ACETATE
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    40000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    80000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        234
        day
      • Milk
        5
        day
    • Horse
      • Meat and offal
        234
        day
      • Milk
        5
        day
    • Pig
      • Meat and offal
        206
        day
    • Sheep
      • Meat and offal
        196
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Interchemie Werken De Adelaar Eesti AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1475
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 27/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."